Country: Brazil Sector: Healthcare Industry: Drug Manufacturers-General Stock Market - Quotes & Prices
List of all Stocks and Equities with Prices, Market Capitalizations, PE and EPS
Brazil (14)
- {{country.name}}
- All countries
- United States (50)
- Argentina (13)
- Australia (1)
- Austria (13)
- Brazil (14)
- Canada (2)
- Chile (4)
- China (22)
- Finland (2)
- France (3)
- Germany (58)
- Hong Kong (4)
- Hungary (1)
- India (20)
- Indonesia (1)
- Italy (5)
- Japan (9)
- Mexico (14)
- Singapore (1)
- South Korea (3)
- Spain (1)
- Sweden (3)
- Switzerland (6)
- Taiwan (1)
- Turkey (1)
- United Kingdom (20)
All exchanges
- {{item.name}}
- All exchanges
- São Paulo (14)
Healthcare (14)
- {{item.name}}
- All sectors
- Healthcare (14)
Drug Manufacturers-General (14)
- {{item.name}}
- All Industries
- Biotechnology (16)
- Drug Manufacturers-General (14)
- Drug Manufacturers-Specialty & Generic (8)
- Healthcare Plans (7)
- Medical Care Facilities (8)
- Pharmaceutical Retailers (4)
- Health Information Services (2)
- Medical Devices (10)
- Medical Instruments & Supplies (8)
- Diagnostics & Research (14)
- Medical Distribution (5)
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
M.Cap Market Cap | VOL Volume | 24h low | 24h high | Market Cap | P/E Ratio | EPS | |
---|---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
Dimed S.A. Distribuidora de Medicamentos PNVL3.SA | $8.64 1.75 USD |
+1.05
|
$1.29B 260.56M USD | $14.3K 2.9K USD | $8.5 1.72 USD | $8.66 1.76 USD | $1.29B 260.56M USD | 12.34 | $0.7 0.14 USD | |
Eli Lilly and Company LILY34.SA | $146.7 29.73 USD |
+3.73
|
$3.95T 801.02B USD | $1.89K 382.26 USD | $141.44 28.67 USD | $147.21 29.84 USD | $3.95T 801.02B USD | 64.34 | $2.28 0.46 USD | |
Johnson & Johnson JNJB34.SA | $58.54 11.87 USD |
-1.89
|
$2.12T 430.01B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.12T 430.01B USD | 26.01 | $2.25 0.46 USD | |
AbbVie Inc. ABBV34.SA | $68.74 13.93 USD |
+1.12
|
$1.95T 395.33B USD | $34 6.89 USD | $68.74 13.93 USD | $68.74 13.93 USD | $1.95T 395.33B USD | 79.01 | $0.87 0.18 USD | |
Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.24T 251.12B USD | 18.28 | $3.43 0.7 USD | |
AstraZeneca PLC A1ZN34.SA | $65.01 13.18 USD |
+1.14
|
$1.21T 245.11B USD | $1 0.2 USD | $65.01 13.18 USD | $65.01 13.18 USD | $1.21T 245.11B USD | 29.68 | $2.19 0.44 USD | |
Merck & Co., Inc. MRCK34.SA | $59.49 12.06 USD |
-4.05
|
$1.2T 243.66B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.2T 243.66B USD | 12.06 | $4.93 1 USD | |
Amgen Inc. AMGN34.SA | $61.01 12.37 USD |
-1.34
|
$917.69B 186B USD | $0 0 USD | $0 0 USD | $0 0 USD | $917.69B 186B USD | 38.61 | $1.58 0.32 USD | |
Gilead Sciences, Inc. GILD34.SA | $311.84 63.2 USD |
-2.16
|
$777.5B 157.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $777.5B 157.59B USD | 278.42 | $1.12 0.23 USD | |
Pfizer Inc. PFIZ34.SA | $33.07 6.7 USD |
-1.67
|
$750.22B 152.06B USD | $0 0 USD | $0 0 USD | $0 0 USD | $750.22B 152.06B USD | 16.05 | $2.06 0.42 USD | |
Bristol-Myers Squibb Company BMYB34.SA | $323.22 65.51 USD |
0
|
$657.68B 133.3B USD | $0 0 USD | $323.22 65.51 USD | $323.22 65.51 USD | $657.68B 133.3B USD | 0 | -$25.78 -5.2 USD | |
GSK plc G1SK34.SA | $41.04 8.32 USD |
0
|
$416.62B 84.44B USD | $0 0 USD | $41.04 8.32 USD | $41.04 8.32 USD | $416.62B 84.44B USD | 21.82 | $1.88 0.38 USD | |
Biogen Inc. BIIB34.SA | $117.12 23.74 USD |
-4.41
|
$103.27B 20.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $103.27B 20.93B USD | 10.79 | $10.85 2.2 USD | |
No favorite stocks
You do not have a favorite stocks yet, please add it to favorites to see it here |
- {{ link.label }} {{link}}